ARCT · Healthcare · $389M
$13.69-0.07%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Among 327 Biotechnology peers
Quarterly Revenue Growth
“매출은 1,700만 달러에서 300만 달러, 200만 달러로 급감한 뒤 이번 분기 300만 달러에 그쳐 회복 신호가 아직 약해요.”
In the company's words · 2026 2분기 earnings call